Xenetic Biosciences reports Q3 results
Source: SeekingAlpha
2025-11-13 10:00:14 ET
More on Xenetic Biosciences
- Xenetic Biosciences prices of $4.5 million offering of common stock; shares down over 14%
- Seeking Alpha’s Quant Rating on Xenetic Biosciences
- Historical earnings data for Xenetic Biosciences
- Financial information for Xenetic Biosciences
Read the full article on Seeking Alpha
For further details see:
Xenetic Biosciences reports Q3 results
Xenetic Biosciences Inc.
NASDAQ: XBIO
XBIO Trading
13.36% G/L:
$2.57 Last:
91,484 Volume:
$2.4259 Open:
XBIO Latest News
December 11, 2025 05:00:00 pm
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
November 19, 2025 08:45:00 am
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
November 13, 2025 08:45:00 am
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
XBIO Stock Data
$4,811,218
1,968,017
0.44%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Framingham
